All In MedTech

Device Trial Radar · NCT05684146

Protect the Head to Head Study

Protect the Head to Head: A Safety and Efficacy Assessment of the Emboliner Embolic Protection Device

Last checked: Nov 19, 2026Latest source record: May 19, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 540 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

540

Planned (sponsor's estimate)

Start

May 4, 2023

Primary completion

Oct 2024

Study completion Dec 2024

Sponsor

Lead sponsor
EmbolineNot on our public-company list
Sponsor type
Industry
First posted
Jan 13, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Prospective, randomized, open label, multicenter, 2-arm, safety and efficacy study

Conditions

  • Embolism

Interventions

  • Emboliner Embolic ProtectionDevice

    Emboliner Embolic Protection Device will be used to capture and remove embolic material during transcatheter aortic valve replacement (TAVR) interventions

  • Sentinel Cerebral ProtectionDevice

    The Sentinel Cerebral Protection System will be used to capture and remove embolic material during transcatheter aortic valve replacement (TAVR) interventions

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Non-inferiorityTime frame: Non-inferiority of 30-day Emboliner device MACCE patient incidence rate compared to the Sentinel device patient incidence rate.

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • NewYork-Presbyterian/Columbia University Medical Center

    New York, New York · Recruiting

  • Oklahoma Heart Institute

    Tulsa, Oklahoma · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.